Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses"

Nanoemulsion adjuvanted COBRA HA vaccine enhances protective antibody titers against H1N1 and H3N2 influenza viruses.

Human vaccines & immunotherapeutics·2026

Serum IgA proteomics reveals clonal composition and neutralization of dimeric and monomeric IgA repertoires against human norovirus.

Proceedings of the National Academy of Sciences of the United States of America·2026

Immunization with N2 neuraminidase can protect mice against a heterologous influenza A virus challenge even in the absence of cross-NA inhibiting antibodies.

mSphere·2026

Antigenic mapping of H2 influenza viruses recognized by ferret and human sera and predicting antigenically significant sites.

mSphere·2026

Serum-antibody Profiling of H3N2-infected Ferrets Using a Combinatorial Phage-display Random Peptide Library.

Journal of molecular biology·2026

Assessment of hemagglutinin-inhibition activity following influenza vaccination during the 2022-2023, 2023-2024, and 2024-2025 seasons.

PloS one·2026

A digitally immune-optimized influenza vaccine broadly neutralizes swine and human H1N1 influenza viruses and protects from heterologous challenge.

Journal of virology·2026

TLR3-TRIF signaling in villus-like enterocytes drives type III interferon responses to enteroviruses.

Journal of virology·2026

Infection and transmission dynamics of bovine and human influenza A H5N1 viruses in mouse and hamster models.

Journal of virology·2026

Protective efficacy of a recombinant pseudorabies virus expressing three copies of PCV2 Cap protein and its ability to decrease PCV2 loads in pigs.

Journal of virology·2026

In vitro and in vivo model systems for Orthoflavivirus antiviral therapeutics: current landscape and strategic considerations.

Journal of virology·2026

Real-time tracking of dual-labeled fluorescent SARS-CoV-2 reveals that the nucleocapsid mutations R203K/G204R accelerate viral uncoating.

Journal of virology·2026

The Individual in Medicine: Why Anomalies Matter.

Journal of evaluation in clinical practice·2026

Reclassification of Noncanonical MET Splice-Site Variants Using RNA-Based Validation: A Practical Diagnostic Approach in Non-Small Cell Lung Cancer.

Turk patoloji dergisi·2026

Evolutionary and structural pathways of antibody maturation reveal principles for engineering potent SARS-CoV-2 neutralizers.

Journal of structural biology: X·2026

High-Throughput DNA Barcoding Identifies Lipid Nanoparticles for Lung Delivery of TRAIL-mRNA to Induce Tumor Cell Death in Experimental Metastasis Model.

International journal of nanomedicine·2026

Segmented poly(A) tails with microRNA target sites confer tissue-specific regulation for mRNA therapeutics.

Molecular therapy. Nucleic acids·2026

TGF-β-induced epithelial to mesenchymal transition drives proteoglycan binding specificity of HPV-based drug conjugates for cancer cells.

Frontiers in oncology·2026

Related Experiment Videos

Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive

Related Concept Videos

Nanoemulsion adjuvanted COBRA HA vaccine enhances protective antibody titers against H1N1 and H3N2 influenza viruses.

Serum IgA proteomics reveals clonal composition and neutralization of dimeric and monomeric IgA repertoires against human norovirus.

Immunization with N2 neuraminidase can protect mice against a heterologous influenza A virus challenge even in the absence of cross-NA inhibiting antibodies.

Antigenic mapping of H2 influenza viruses recognized by ferret and human sera and predicting antigenically significant sites.

Serum-antibody Profiling of H3N2-infected Ferrets Using a Combinatorial Phage-display Random Peptide Library.

Assessment of hemagglutinin-inhibition activity following influenza vaccination during the 2022-2023, 2023-2024, and 2024-2025 seasons.

A digitally immune-optimized influenza vaccine broadly neutralizes swine and human H1N1 influenza viruses and protects from heterologous challenge.

TLR3-TRIF signaling in villus-like enterocytes drives type III interferon responses to enteroviruses.

Infection and transmission dynamics of bovine and human influenza A H5N1 viruses in mouse and hamster models.

Protective efficacy of a recombinant pseudorabies virus expressing three copies of PCV2 Cap protein and its ability to decrease PCV2 loads in pigs.

In vitro and in vivo model systems for Orthoflavivirus antiviral therapeutics: current landscape and strategic considerations.

Real-time tracking of dual-labeled fluorescent SARS-CoV-2 reveals that the nucleocapsid mutations R203K/G204R accelerate viral uncoating.

The Individual in Medicine: Why Anomalies Matter.

Reclassification of Noncanonical MET Splice-Site Variants Using RNA-Based Validation: A Practical Diagnostic Approach in Non-Small Cell Lung Cancer.

Evolutionary and structural pathways of antibody maturation reveal principles for engineering potent SARS-CoV-2 neutralizers.

High-Throughput DNA Barcoding Identifies Lipid Nanoparticles for Lung Delivery of TRAIL-mRNA to Induce Tumor Cell Death in Experimental Metastasis Model.

Segmented poly(A) tails with microRNA target sites confer tissue-specific regulation for mRNA therapeutics.

TGF-β-induced epithelial to mesenchymal transition drives proteoglycan binding specificity of HPV-based drug conjugates for cancer cells.

Related Experiment Videos

Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive...

Related Concept Videos

Related Articles

Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive